Local insulin infusion stimulates expression of plasminogen activator inhibitor-1 and tissue-type plasminogen activator in normal subjects (Q73096122)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527036%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Local insulin infusion stimulates expression of plasminogen activator inhibitor-1 and tissue-type plasminogen activator in normal subjects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527036%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527036%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

M Morale

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527036%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

L Ferrini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527036%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

G Dell'Omo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527036%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Ferdeghini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527036%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

R Pedrinelli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527036%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

F De Negri

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527036%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 October 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527036%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527036%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527036%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527036%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

344-350

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527036%20AND%20SRC:MED&resulttype=core&format=json

Plasminogen activator inhibitors

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

The PA‐Plasmin System during Murine Embryogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

The fibrinolytic system in neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Fibrinolysis and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Regulation of plasminogen activator inhibitor-1 levels in human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

The adipocyte and hemostatic balance in obesity: studies of PAI-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Stimulating effect of oxidized low density lipoproteins on plasminogen activator inhibitor-1 synthesis by endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Stimulation by Proinsulin of Expression of Plasminogen Activator Inhibitor Type-I in Endothelial Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Augmentation of arterial endothelial cell expression of the plasminogen activator inhibitor type-1 (PAI-1) gene by proinsulin and insulin in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Short-term infusions of insulin, triacylglycerol and glucose do not cause acute increases in plasminogen activator inhibitor-1 concentrations in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Effects of insulin on hemodynamics and metabolism in human forearm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Pathophysiology of fibrinolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

The fibrinolytic enzyme system and its role in the etiology of thromboembolic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Fibrin(ogen) and diabetes mellitus: don't forget fibrinolysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Direct vasodilator effects of physiological hyperinsulin-aemia in human skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Fluid flow stimulates tissue plasminogen activator secretion by cultured human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Perfused rat hindlegs. A model to study plasminogen activator release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for 'second-site' interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Impaired insulin-induced attenuation of noradrenaline-mediated vasoconstriction in insulin-resistant obese Zucker rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Polycystic ovary syndrome: symptomatology, pathophysiology, and epidemiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

Gene manipulation and transfer of the plasminogen and coagulation system in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900240-5

10.1016/S0002-9343(99)00240-5

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527036%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference